
|Articles|October 1, 2001
- Pharmaceutical Executive-10-01-2001
Leap of Faith: Branding and ROI
Not only did Shakespeare know a great deal about human nature, he knew something about brand equity: a name has value. Four hundred years later, marketers grapple to understand the association between brands and profitability.
Advertisement
Articles in this issue
over 24 years ago
Never Say “No Comment”Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals
5




